Bottom line GLP-1 medications, or glucagon-like peptide-1 receptor agonists, treat type 2 diabetes and, in some cases, obesity
calcium-activated calpains and ubiquitin-proteolytic pathway) as well as apoptosis
Although strict glycemic control has beneficial effects on microvascular complications (retinopathy, nephropathy or neuropathy), it does not seem to reduce the risk of cardiovascular disease, and it is associated with an increased risk of hypoglycemia in patients with DM2.3,6 Until recently, the antihyperglycemic drugs available have improved glycemic control, but without much benefits on cardiovascular and/or renal risk
By harnessing your own biology, PRP offers a personalized solution to hair loss that feels both natural and effective
Why does this product have a grainy consistency